NCT04015011

Brief Summary

Total Knee Replacement (TKR) significantly improves function, pain, and overall quality of life in patients with end-stage arthritis of the knee. However, studies show that obesity increases complications and costs associated with TKR. The American Academy of Orthopaedic Surgeons (AAOS) clinical guidelines recommend that patients with a BMI \> 25kg/m2 lose 5% of their body weight prior to surgery. Consequently, although it is not clear how to patients or providers achieve weight loss in this population, some providers and hospitals decline to perform TKR in patients with obesity. Low Calorie meal replacement diets (LCD) are a feasible way to safely promote short-term weight loss of 8-15% at 3-6 months prior to some elective surgeries. This is a pilot efficacy study to test whether a short-term program using a 3-month LCD leads to weight loss and improved patient reported and functional outcomes. 75 patients eligible for knee replacement surgery and willing to undergo non-operative weight management treatment at NYU Langone Comprehensive Obesity Center. This study will establish feasibility and weight loss outcomes in preparation for a multicenter effectiveness trial.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Jul 2019

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 10, 2019

Completed
15 days until next milestone

Study Start

First participant enrolled

July 25, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2021

Completed
Last Updated

April 8, 2022

Status Verified

March 1, 2022

Enrollment Period

11 months

First QC Date

June 26, 2019

Last Update Submit

March 31, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in weight

    Patients who have had recent knee replacement will be weighed at screening, week 5-7, week 11-13, and 30-120 days post surgery

    up to 18 Months

  • Change in mobility during 30-sec chair stand

    18 Months

  • Change in mobility during 40-meter fast paced walk

    18 Months

  • Change in quality of life measured by SF-36 questionnaire

    The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability. To calculate the scores it is necessary to purchase special software. Pricing depends on the number of scores that the researcher needs to calculate. The eight sections are: * vitality * physical functioning * bodily pain * general health perceptions * physical role functioning * emotional role functioning * social role functioning * mental health

    18 Months

Study Arms (1)

Low Calorie Diet (LCD) diet intervention

EXPERIMENTAL

In person or video conference

Combination Product: LCD Intervention

Interventions

LCD InterventionCOMBINATION_PRODUCT

composed of approximately 1,080 kcal/day, which includes 3 New Direction Meal Replacements containing 200 kcal (27g protein, 12g carbhydrate, 2g fiber), 1 protein bar containing 160 kcal (5 g protein, 18g carbohydrate, 5g fiber, 2g sugar alcohol), and a 350-calorie controlled meal of protein and vegetables that the patient will make on his/ her own.

Low Calorie Diet (LCD) diet intervention

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • BMI 35-45 kg/m2
  • Any ethnicity
  • Able to speak, read, and write in English
  • Have knee replacement surgery already planned by the surgeon
  • Plan to undergo knee replacement surgery within 3-6 months post LCD intervention
  • Willing to commute to NYU Langone Weight Management Clinic at the start of the dietary intervention, midway through, and end of intervention

You may not qualify if:

  • Uncontrolled type 2 diabetes, defined as HbA1c \> 9%
  • If smokes cigarettes, must go through a 6 week cessation program first
  • Type 1 diabetes
  • Whey protein allergies
  • Soy allergies
  • Anyone in whom rapid weight loss is not indicated (e.g., ESRD or cirrhosis, metabolic cancer, abnormal 3 times UL liver enzyme labs)
  • Current untreated or uncontrolled eating disorder (e.g., binge eating, bulimia)
  • Rheumatoid arthritis
  • In case a previous knee replacement surgery was done, the participant should wait at least 1 year from previous date of surgery
  • Undergoing simultaneous bilateral knee replacement
  • Enrolled in a formal weight loss program
  • Taking anti-obesity medications
  • Coexisting psychotic conditions requiring hospitalization or more intense treatment (e.g., bipolar mood disorder, severe depression)
  • Abnormal CBC, and uric acid, must be treated prior to start of intervention
  • Higher than 5.5 mU/L or lower than 0.3 mU/L TSH must be treated prior to start of LCD intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NYU Langone Health

New York, New York, 10016, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2019

First Posted

July 10, 2019

Study Start

July 25, 2019

Primary Completion

June 30, 2020

Study Completion

September 30, 2021

Last Updated

April 8, 2022

Record last verified: 2022-03

Locations